Clinical Stage IV Gastric Cancer AJCC v8 Recruiting Phase 1 Trials for Nivolumab (DB09035)

IndicationStatusPhase
DBCOND0113387 (Clinical Stage IV Gastric Cancer AJCC v8)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05802056Aldesleukin With Nivolumab and Standard Chemotherapy for Treatment of Gastric Cancer With Peritoneal MetastasisTreatment